Cargando…
Authorized SARS-CoV-2 molecular methods show wide variability in the limit of detection.
On February 29(th), 2020, the U.S. Food and Drug Administration issued the first Emergency Use Authorization (EUA) for a SARS-CoV-2 assay outside of the U.S. Centers for Disease Control and Prevention. As of May 3(rd), 2021, 289 total EUAs have been granted. Like influenza, there is no standard for...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751006/ https://www.ncbi.nlm.nih.gov/pubmed/36669396 http://dx.doi.org/10.1016/j.diagmicrobio.2022.115880 |